RK more than halved circulating IL‐6 concentrations in tumour‐bearing mice and diminished STAT3 phosphorylation in adipose and muscle tissue, indicating that reducing systemic IL‐6 levels, and thereby limiting tissue STAT3 signalling, likely contributes to the beneficial effect of RK in tumour‐bearing mice. The gene discussed is STAT3; the disease is neoplasm.